You are using an outdated browser. Please upgrade your browser to improve your experience.

We partner across the globe to address disease surveillance gaps.

Our Team

Mark Smolinski, MD, MPH


Mark Smolinski brings 25 years of experience in applying innovative solutions to improve disease prevention, response, and control across the globe. Mark is leading a well-knit team—bringing together technologists; human, animal, and environmental health experts; and key community stakeholders to co-create tools for early detection, advanced warning, and prevention of pandemic threats. Community health workers, village volunteers, farmers, and interested public citizens in Albania, Brazil, Cambodia, Europe, Laos, Myanmar, Tanzania, Thailand, and the United States are among those using their own solutions to address pressing local needs. Since 2009, Mark has served as the Chief Medical Officer and Director of Global Health at the Skoll Global Threats Fund (SGTF), where he developed the Ending Pandemics in Our Lifetime Initiative in 2012. His work at SGTF created a solid foundation for the work of Ending Pandemics, which branched out as an independent entity on January 1, 2018.

Prior to SGTF, Mark developed the Predict and Prevent Initiative at, as part of the starting team at Google’s philanthropic arm. Working with a team of engineers, Google Flu Trends (a project that had tremendous impact on the use of big data for disease surveillance) was created in partnership with the U.S. Centers for Disease Control. Mark has served as Vice President for Biological Programs at the Nuclear Threat Initiative, a public charity directed by CNN founder Ted Turner and former U.S. Senator Sam Nunn. Before NTI, he led an 18-member expert committee of the National Academy of Medicine on the 2003 landmark report “Microbial Threats to Health: Emergence, Detection, and Response.” Mark served as the sixth Luther Terry Fellow in Washington, D.C., in the Office of the U.S. Surgeon General and as an Epidemic Intelligence Officer with the U.S. Centers for Disease Control and Prevention.

Mark received his BS in Biology and MD from the University of Michigan in Ann Arbor. He is board-certified in preventive medicine and public health and holds an M.P.H. from the University of Arizona, where he was recognized as the 2016 Alumnus of the Year. Mark was on the investigation team that discovered hantavirus, a newly identified pathogen, in 1993. His passion for helping all peoples of the world save lives and improve livelihoods motivates partners on five continents.

Louise S. Gresham, PhD, MPH

Special Initiatives

Louise Gresham brings her extensive experience in disease surveillance and international public health practice to shape the collaborative and evidence-based approach in Ending Pandemics’ mission.  Louise provides technical support to Connecting Organizations for Regional Disease Surveillance (CORDS) and the Ending Pandemics Collective (EPC), an assembly of nearly 20 organizations committed to ending epidemics and preventing pandemics.

At the Nuclear Threat Initiative in Washington D.C., Louise directed regional infectious disease surveillance activities in the Middle East, Southeast Asia, and Southern Africa.  Louise is a member of the delegation that developed the first modern tuberculosis laboratory in the DPRK North Korea with the humanitarian group CFK and with Stanford University. She advised the Bipartisan WMD Center, chaired by U.S. Senators Graham and Talent.

Louise served as Senior Epidemiologist for the San Diego County Health and Human Services Agency and retains her adjunct Associate Professor appointment with the Graduate School of Public Health at San Diego State University, California.

Marlo Libel, MD, MPH

Senior Advisor

Marlo Libel applies over 40 years of public health surveillance experience to the goal of ending pandemics. He provides sound advice and strategic direction, along with technical support to CORDS (Connecting Organizations for Regional Disease Surveillance) and EpiCore, a global crowdsourcing network of volunteer human, animal, and environmental practitioners committed to verifying disease outbreaks. Marlo previously worked with Ending Pandemics at the Skoll Global Threats Fund on a variety of projects. He led the SGTF project on participatory surveillance for early detection of disease outbreaks at mass gatherings (2014 World Cup and 2016 Olympics, both in Brazil).

Marlo was a medical epidemiologist at the Pan American Health Organization (PAHO/WHO) from 1985–2009. Initially stationed in Panama, he directed the technical cooperation in Central America to improve public health surveillance systems, outbreak investigation and control, and HIV/AIDS surveillance and prevention strategies. From 1989 onward, at PAHO’s headquarters in Washington, D.C., he served as regional advisor on communicable diseases with responsibility for coordinating PAHO’s response to disease outbreaks. His work also included establishing emerging infectious disease networks in the Southern Cone, the Amazon Basin, and Central America and acting as regional focal point for the implementation of IHR (2005). He received his MD from the Faculdade Catolica de Medicina de Porto Alegre, Brazil, and his MPH from the Tulane School of Tropical Medicine and Hygiene.


Nomita Divi, MSPH


Nomita Divi oversees the implementation of a highly evolving work plan and manages the team. Her areas of expertise include stakeholder engagement, management, needs assessment, and program planning. Nomita developed a portfolio of projects while serving as Program Officer on the Ending Pandemics team at the Skoll Global Threats Fund, including network-building in South Asia, crowdsourcing epidemics intelligence for verification of outbreaks, and formulating creative opportunities to engage with technologists. Nomita spent eight years at Stanford University managing various health policy programs. Before her time at Stanford, she worked at Massachusetts General Hospital, managing the application of a global HIV simulation model in India, South Africa, Cote d’Ivore, and the Caribbean.

Nomita holds a Bachelor of Science in Biology from the University of Ottawa, Canada as well as a Masters of Science in Public Health from the Harvard School of Public Health.

Adam Crawley, MPH

Program Officer

Adam Crawley provides project oversight and technical support to Ending Pandemics and its partners. This includes data analysis, surveillance system design, and evidence base documentation for Ending Pandemics’ impact. Adam began this work as a Research Associate at the Skoll Global Threats Fund, where he helped measure outbreak detection timeliness and response in 28 partner countries and worked with our partners at HealthMap to refine and expand Flu Near You as a self-tracking system to monitor influenza-like illness in North America. Prior to SGTF, Adam served as Interim Supervising Epidemiologist at the San Mateo County Health System and as a Senior Research Associate at the UC Berkeley Center for Infectious Diseases and Emergency Readiness.

Adam holds a Bachelor of Arts in International Politics from the University of Rhode Island and a Masters of Public Health from the UC Berkeley School of Public Health, with a concentration in Infectious Diseases and Vaccinology.

Lauren Diaz

Operations and Finance Manager

Lauren Diaz oversees administrative controls, reporting procedures, and people systems to effectively and efficiently grow the organization and ensure financial strength. Lauren rapidly ascended the ranks at the Skoll Global Threats Fund, moving from Team Administrator to Operations Associate in less than four years. Prior to SGTF, Lauren worked on fundraising activities at the Salvation Army, Golden State Division Headquarters. Lauren was also a WorldTeach English teacher at the Escuela Politecnica Nacional University in Quito, Ecuador where she taught intermediate and advanced English courses.

Lauren holds a Bachelor of Arts in Political Science and Communication Studies from the University of San Diego.

Prapapan Phetra


Prapapan Phetra has been working with the Ending Pandemics team on the planning and implementation of EpiHacks™ across the globe since 2012.

Prapapan runs her own software business in Thailand, Business On Network Co. Ltd., where she provides counsel and IT solutions with open-source technologies for NGOs, academia, public and private sector industries.

Jaś Mantero, MD, PhD


Jaś Mantero supports Ending Pandemics in applying innovations to disease surveillance across hard to reach communities.

He has worked in the field of public health for the past 15 years with a focus on early detection, verification, assessment, and response at various agencies including the World Health Organization, European Centre for Disease Prevention & Control, Doctors without Borders (MSF), and the European Union.

Jaś works as an independent Public Health consultant covering epidemic intelligence and health risk assessment tasks for governmental institutions.

Board Of Directors

Larry Brilliant, MD, MPH

Board Chairman

Dr. Larry Brilliant is the author of ‘Sometimes Brilliant: The Impossible Adventures of a Spiritual Seeker and Visionary Physician Who Helped Conquer the Worst Disease in History.’ He currently serves as the Chairman of the Advisory Board for Ending Pandemics. Larry is also a Senior Advisor at the Jeff Skoll Group. He previously served as the Skoll Global Threats Fund’s President and CEO, the Vice President of Google, and as a founding Executive Director of

Dr. Brilliant is board certified in preventive medicine and lived in India for more than a decade working as a United Nations medical officer where he played a key role in the successful World Health Organization (WHO) smallpox eradication program in South Asia. He is also the co-founder of The Seva Foundation, an international NGO with programs and grantees that have given back sight to more than 5 million blind people in over 20 countries.

He has worked with four Presidents, the United Nations, G8, and Chaired the National Biosurveillance Advisory Subcommittee. He co-founded one of the first digital social networks, the Well. He was also a professor at the University of Michigan and founding chairman of the National Biosurveillance Advisory Subcommittee.

Dr. Brilliant has been recognized as one of the “100 Most Influential People,” by Time Magazine, received the TED Prize, and has four honorary doctorates. He currently serves on the boards of Skoll Foundation, Salesforce Foundation, and Dharma Platform.

Margaret Hamburg, MD

Dr. Hamburg is an internationally recognized expert in medicine and public health as well as a leading authority on emergency preparedness and response.

Currently, Dr. Hamburg is the Foreign Secretary for the National Academy of Medicine, where she serves as senior advisor on international matters and is the liaison with other Academies of Medicine around the world. She is also the President of the American Association for the Advancement of Science (AAAS), the world’s largest scientific membership organization.

Prior to this, President Obama appointed her to serve as Commissioner of the Food and Drug Administration (FDA). In this role she was known for advancing regulatory science, medical product innovation and the globalization of the agency, while also overseeing the implementation of groundbreaking laws to curb tobacco use and enhance food safety.

Previously, Dr. Hamburg served as Vice President and as a Senior Scientist at the Nuclear Threat Initiative, a foundation dedicated to reducing nuclear, chemical and biological threats. Dr. Hamburg also served as New York City Health Commissioner, where she undertook major initiatives to address HIV/AIDS, curtail the resurgence and spread of tuberculosis, and launched the nation’s first public health bioterrorism preparedness program. President Clinton later named her Assistant Secretary for Planning and Evaluation for the U.S. Department of Health and Human Services, the chief policy role in the department. Dr Hamburg also served as the Assistant Director of the National Institute of Allergy and Infectious Diseases, National Institutes of Health.

Suwit Wibulpolprasert, MD

Dr. Suwit Wibulpolprasert is a general practitioner, a public health specialist, an administrator, and a policy advocator. He was the Director of the Northeastern Public Health College, Director of Technical Division of the FDA, Director of Bureau of Health Policy and Planning, Assistant Permanent Secretary, Deputy Permanent Secretary and Senior Advisor at the Thai Ministry of Public Health.

He has been extensively involved in research and development covering many areas of health including human resources, economics, financing, international trade, information, advocacy, and pharmaceuticals. Dr. Wibulpolprasert has published more than 100 papers, reports, and books locally and internationally.

He currently chairs the Steering Committee of the Asia Partnership on Avian Influenza Research and the Steering Committee of the Asia-Pacific Action Alliance on Human Resources for Health. He is also a member and Chair of the Program Coordinating Board of the UNAIDS, and member and Chair of the Program and Policy Committee of the interim Board of the Global Health Workforce Alliance.

Dr. Wibulpolprasert served as a Deputy Permanent Secretary of the Thai Ministry of Public Health, in 2000-2003. Currently, he serves as the highest-ranking government official as a Senior Advisor in Disease Control, after serving as a Senior Advisor in Health Economics during 2003-2006. He is also responsible for Health Policy and International Health Works of the Ministry.

Taha A. Kass-Hout, MD, MS

Taha A. Kass-Hout, MD, MS is a senior leader at Amazon focusing on health care and AI-related initiatives, including Amazon Comprehend Medical. The expansion of AWS Comprehend into medicine is the first health care-specific machine learning service offered by AWS. Taha has a successful track record over the past two decades pioneering in health care and life sciences, digital health, big data, open science, precision medicine, crowdsourcing, and cloud. He served as the first Chief Health Informatics Officer for the U.S. Food and Drug Administration (FDA) (2013-2016). During that time, he created multiple innovations, including openFDA and precisionFDA. OpenFDA is a big data cloud platform that provides open source Application Programming Interfaces (APIs) enabling a large community of software developers, researchers, scientists, and the public to search and analyze adverse events, recalls, and labeling for most medical products in the market. PrecisionFDA is the bioinformatics cloud platform for ensuring the accuracy of Next Generation Sequencing (NGS) genetic tests by crowdsourcing reference material and data, and part of President Obama’s 2015 Precision Medicine Initiative. Both platforms were referenced in the 2015 White House updated Strategy for American Innovation, and precisionFDA was awarded the top prize at the 2016 Bio-IT World Best Practices. Taha spearheaded groundbreaking programs at the U.S. Centers for Disease Control and Prevention (CDC) for electronic disease surveillance and early disease detection, including BioSense 2.0 (2009-2013), and at InSTEDD (founded by Google, Inc. in 2006) where he led the automated early warning and response for natural disasters and pandemics (2006-2009). In 2010, the Thomson Reuter Foundation used InSTEDD’s cloud platform to launch a first-of-its kind, free disaster-information service for the people of Port Au Prince, Haiti after a devastating earthquake there. He also served as the SVP and Chief Digital Health and Analytics Officer at Trinity Health (2016-2017), one of the leaders in value-based health care systems in the U.S. and advised the American Heart Association, where he was an integral part of the development of AHA’s Precision Medicine cloud platform. Taha received his medical training at Harvard’s Beth Israel Deaconess Medical Center, and holds a Doctor of Medicine and a Master of Science (Biostatistics) from the University of Texas Health Science Center at Houston.